| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 918,492 | 1,029,316 | 935,594 | 922,947 | | Cost of Revenue | 216,978 | 108,128 | 266,330 | 258,050 | | | Gross Profit | 701,514 | 921,188 | 669,264 | 664,897 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 67,946 | 201,140 | 45,650 | 42,093 | | Non Recurring |
-
| (17,367) | 17,367 |
-
| | Others | 269,352 | 292,937 | 222,552 | 243,398 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 364,216 | 444,478 | 383,695 | 379,406 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (21,172) | 4,252 | (24,582) | | Earnings Before Interest And Taxes | 372,284 | 536,780 | 364,048 | 320,252 | | Interest Expense | 226,036 | 244,933 | 239,955 | 232,335 | | Income Before Tax | 146,248 | 291,847 | 124,093 | 87,917 | | Income Tax Expense | (2,523) | 2,005 | 972 | 627 | | Minority Interest |
-
| 92,712 | (35,987) | (26,804) | | | | Net Income From Continuing Ops | 146,248 | 288,266 | 124,093 | 87,917 | | | Non-recurring Events | | Discontinued Operations |
-
| (25) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 146,248 | 288,241 | 124,093 | 87,917 | | Preferred Stock And Other Adjustments | (39,480) | (143,038) | (11,284) | (11,345) | | | Net Income Applicable To Common Shares | $106,768 | $145,203 | $112,809 | $76,572 |
|
0.45% Nasdaq 
0.20%
Income Statement
